期刊文献+

介入治疗8例肝豆状核变性并发严重门静脉高压的疗效 被引量:1

Interventional treatment of severe portal hypertension due to hepatolenticular degeneration:therapeutic evaluation of 8 cases
下载PDF
导出
摘要 目的评价介入治疗肝豆状核变性所致门脉高压的疗效。方法分析世纪坛医院介入治疗科8例合并严重门静脉高压的肝豆状核变性患者治疗情况,采用经皮穿刺胃冠状静脉栓塞或部分脾动脉栓塞治疗,比较手术前后血象和门脉压力变化。结果 所有病例均未再出现严重门静脉高压的表现,白细胞于术后1周内明显升高,2周后恢复至正常范围;血小板于术后第2周以后逐渐恢复至正常范围。术后门静脉压力略有升高,但差异无统计学意义。结论介入治疗可缓解肝豆状核变性导致的门静脉高压症,有利于继续恢复驱铜药物治疗。 Objective To evaluate the therapeutic efficacy of sclerotic embolization of esophagogastric varices(SEEV)and partial splenic embolization(PSE)in treating esophagogastric varices and portal hypertension,respectively,in patients with hepatolenticular degeneration.Methods Eight patients with severe portal hypertension complicated with upper gastrointestinal bleeding and hypersplenism were involved in this study.White blood cell(WBC)counts,platelet counts,and portal vein pressure were determined before and after operation,the results were compared with each other.Results No recurrence or complication occurred after operation in all patients.After the treatment(SEEV and PSE)the hepatic function showed no obvious changes.The WBC counts increased obviously in the first week after operation,and returned to normal range in 2 weeks.The platelet counts gradually returned to normal level from the second week.The portal vein pressure after operation went up a little,from(45.13 ± 8.69) cm H2O to(48.63 ± 10.48) cm H2O in SEEV group and to(47.88 ± 11.43) cm H2O in PSE group,but the difference was of no statistic significance(P 〉0.05).Conclusion Interventional therapy can reduce the portal hypertension caused by hepatolenticular degeneration.The technique is safe and effective,and is very helpful for returning to anti-copper treatment.
出处 《介入放射学杂志》 CSCD 北大核心 2011年第3期224-227,共4页 Journal of Interventional Radiology
基金 2010年北京市科技计划项目"首都特色临床医学应用发展"基金资助 (项目编号:Z101107050210023)
关键词 肝豆状核变性 门脉高压 介入治疗 疗效评价 hepatolenticular degeneration portal hypertension interventional therapy therapeutic effect
  • 相关文献

参考文献7

  • 1Khanna A, Jain A, Eghtesad B, et al. Liver transplantation for metabolic liver diseases [J]. Surg Clin North Am, 1999, 79: 153 - 162.
  • 2Subramanian I, Vanek ZF, Bronstein JM. Diagnosis and treat- ment of Wilson's disease [J]. Curr Neurol Neurosci Rep, 2002, 2:317 - 323.
  • 3Shilyansky J, Roberts EA, Superina RA. Distal splenorenal shu- nts for the treatment of severe thrombocytopenia from portal hypertension in children [J]. J Gastrointest Surg, 1999, 3 (2) : 167- 172.
  • 4Hermann RE, Henderson JM, Vogt DP, et al. Fifty years of surgery for portal hypertension at Cleveland Clinical Foundation, Lesson and prospects[J]. Ann Surg, 1995, 221 : 459 - 466.
  • 5Kokai H, Sato Y, Yamamoto S, et al. Successful super-small-forsize graft liver transplantation by decompression of portal hypertension via splenectomy and construction of a mesocaval shunt:a case report [J]. Transplant Proc, 2008, 40: 2825 - 2827.
  • 6王作仁,牛新捷,耿智敏,仵正,张云峰,吴胜利.脾切除、贲门周围血管离断术在肝豆状核变性中的治疗地位[J].中华肝胆外科杂志,2003,9(10):594-595. 被引量:3
  • 7汪晓明,张福忠,于庆生,侯勇,沈瑜,易维真.脾切除治疗小儿肝豆状核变性合并脾功能亢进的疗效分析[J].肝胆胰外科杂志,2007,19(4):217-219. 被引量:3

二级参考文献10

共引文献3

同被引文献8

  • 1Conn HO, Rfissle M, Levy L, et al. Portosystemic myelopathy: spastic paraparesis after portosystemic shunting. Scand J Gastroentero1,2006,41:619-625.
  • 2Yin YH, Ma ZJ, Guan YH, et al. Clinical features of hepatic myelopathy in patients with chronic liver disease. Postgrad Med J, 2009,85:64-68.
  • 3Wang MQ, Dake MD, Cui ZP, et al. Portal-systemic myelopathy after transjugular intrahepatic portosystemic shunt creation: report of four cases. J Vasc Interv Radiol,2001,12 :879-881.
  • 4Stracciari A, Guarino M, Pazzaglia P, et al. Acquired hepato- cerebral degeneration: full recovery after liver transplantation. J Neurol Neurosurg Psychiatry,2001,70 : 136-137.
  • 5Pinarbasi B, Kaymakoglu S, Matur Z, et al. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? . J Clin Gastroentero1,2009,43 : 176-181.
  • 6Romeiro FG, Amrico MF, Yamashiro FS, et al. Acquired hepatocerebral degeneration and hepatic encephalopathy : correlations and variety of clinical presentations in overt and subclinical liver disease. Arq Neuropsiquiatr,2011,69 :496-501.
  • 7王洪波,刘振文.肝性脊髓病研究新进展[J].实用肝脏病杂志,2009,12(5):393-396. 被引量:16
  • 8刘福全,岳振东,赵洪伟,王磊,李志伟,余灵祥,李捍卫,金波,范振华,赵孟菲,姚健楠,左力.经颈静脉肝内门-体分流术后再次介入治疗肝硬化门静脉高压长期疗效及再次手术原因分析[J].中华放射学杂志,2012,46(9):830-835. 被引量:14

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部